Correction

Published on 24 Feb 2022

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

in Pharmacology of Anti-Cancer Drugs

Huijuan Liu
Honglian Tao
Hongqi Wang
Yuyan Yang
Ru Yang
Xintong Dai
Xiujuan Ding
Haidong Wu
Shuang Chen
Tao Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.830506

1,411 views
1 citation

Original Research

Published on 24 Feb 2022

Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922

in Pharmacology of Anti-Cancer Drugs

Chun-Xia He
You Lv
Meng Guo
Huan Zhou
Wei Qin
Dong Zhao
Hui-Jin Li
Lu Xing
Xin Zhou
Peng-Quan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.847556

1,668 views
4 citations

Review

Published on 23 Feb 2022

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives

in Pharmacology of Anti-Cancer Drugs

Lucia Musacchio
Carlo Maria Cicala
Vanda Salutari
Floriana Camarda
Maria Vittoria Carbone
Viola Ghizzoni
Elena Giudice
Camilla Nero
Maria Teresa Perri
Caterina Ricci

Frontiers in Oncology

doi 10.3389/fonc.2022.831612

3,117 views
6 citations

Systematic Review

Published on 23 Feb 2022

Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Jiaqi Hu
Juling Jiang
Rui Liu
Mengqi Cheng
Guanghui Zhu
Shulin He
Bolun Shi
Yuwei Zhao
Zhongning He
Huibo Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.828450

3,476 views
5 citations

Original Research

Published on 21 Feb 2022

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer

in Pharmacology of Anti-Cancer Drugs

Yue Zhou
Qing Zhang
Minjia Wang
Chengzhi Huang
Xueqing Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.827891

3,385 views
10 citations

Original Research

Published on 16 Feb 2022

The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression

in Pharmacology of Anti-Cancer Drugs

Renbo Guo
Yiran Liang
Benkui Zou
Danyang Li
Zhen Wu
Fei Xie
Xu Zhang
Xiangzhi Li

Frontiers in Oncology

doi 10.3389/fonc.2022.842967

2,985 views
6 citations

Review

Published on 15 Feb 2022

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Kunzhe Wu
Beibei Yu
Di Li
Yangyang Tian
Yan Liu
Jinlan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.805978

5,902 views
26 citations

Original Research

Published on 14 Feb 2022

Network Pharmacology Study and Experimental Validation of Yiqi Huayu Decoction Inducing Ferroptosis in Gastric Cancer

in Pharmacology of Anti-Cancer Drugs

Siyuan Song
Fang Wen
Suping Gu
Peixin Gu
Wenjie Huang
Shuai Ruan
Xiaoxue Chen
Jiayu Zhou
Ye Li
Jiatong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.820059

18,998 views
16 citations

Original Research

Published on 14 Feb 2022

Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells

in Pharmacology of Anti-Cancer Drugs

Andrea Bileck
Patricia Bortel
Michelle Kriz
Lukas Janker
Endre Kiss
Christopher Gerner
Giorgia Del Favero

Frontiers in Oncology

doi 10.3389/fonc.2021.746411

5,578 views
13 citations

Case Report

Published on 14 Feb 2022

Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report

in Pharmacology of Anti-Cancer Drugs

Zhan Wang
Yan Geng
Ling-Yan Yuan
Miao-Miao Wang
Chen-Yang Ye
Li Sun
Wei-Ping Dai
Yuan-Sheng Zang

Frontiers in Oncology

doi 10.3389/fonc.2022.761558

3,123 views
23 citations

Case Report

Published on 14 Feb 2022

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

in Pharmacology of Anti-Cancer Drugs

Qing Ma
Lingping Kong
Diansheng Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.804330

3,129 views
11 citations

Review

Published on 10 Feb 2022

Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies

in Pharmacology of Anti-Cancer Drugs

Yanping Li
Ruoqiu Fu
Tingting Jiang
Dongyu Duan
Yuanlin Wu
Chen Li
Ziwei Li
Rui Ni
Li Li
Yao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.804212

9,949 views
15 citations

Original Research

Published on 10 Feb 2022

Potential Influence of Anesthetic Interventions on Breast Cancer Early Recurrence According to Estrogen Receptor Expression: A Sub-Study of a Randomized Trial

in Pharmacology of Anti-Cancer Drugs

Mohan Li
Yuelun Zhang
Lijian Pei
Zhiyong Zhang
Gang Tan
Yuguang Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.837959

2,283 views
8 citations

Correction

Published on 10 Feb 2022

Corrigendum: Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

in Pharmacology of Anti-Cancer Drugs

Zhiming Jiao
Zhanchun Feng
Ziqi Yan
Jinwen Zhang
Gang Li
Ganyi Wang
Qianyu Wang
Da Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.859596

939 views
1 citation

Systematic Review

Published on 09 Feb 2022

Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients

in Pharmacology of Anti-Cancer Drugs

Shuai Jiang
Shuai Geng
Qian Chen
Chen Zhang
Mengfei Cheng
Yang Yu
Shuo Zhang
Ning Shi
Mei Dong

Frontiers in Oncology

doi 10.3389/fonc.2022.823705

6,637 views
22 citations

Original Research

Published on 07 Feb 2022

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Olesya Vakhrusheva
Holger H. H. Erb
Vitus Bräunig
Sascha D. Markowitsch
Patricia Schupp
Patrick C. Baer
Kimberly Sue Slade
Anita Thomas
Igor Tsaur
Martin Puhr

Frontiers in Oncology

doi 10.3389/fonc.2022.789284

6,480 views
17 citations

Navigation group

Articles

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives

Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer

The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma

Network Pharmacology Study and Experimental Validation of Yiqi Huayu Decoction Inducing Ferroptosis in Gastric Cancer

Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells

Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies

Potential Influence of Anesthetic Interventions on Breast Cancer Early Recurrence According to Estrogen Receptor Expression: A Sub-Study of a Randomized Trial

Corrigendum: Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells